27987038|t|Efficient genome editing of differentiated renal epithelial cells
27987038|a|Recent advances in genome editing technologies have enabled the rapid and precise manipulation of genomes, including the targeted introduction, alteration, and removal of genomic sequences. However, respective methods have been described mainly in non-differentiated or haploid cell types. Genome editing of well-differentiated renal epithelial cells has been hampered by a range of technological issues, including optimal design, efficient expression of multiple genome editing constructs, attainable mutation rates, and best screening strategies. Here, we present an easily implementable workflow for the rapid generation of targeted heterozygous and homozygous genomic sequence alterations in renal cells using transcription activator-like effector nucleases (TALENs) and the clustered regularly interspaced short palindromic repeat (CRISPR) system. We demonstrate the versatility of established protocols by generating novel cellular models for studying autosomal dominant polycystic kidney disease (ADPKD). Furthermore, we show that cell culture-validated genetic modifications can be readily applied to mouse embryonic stem cells (mESCs) for the generation of corresponding mouse models. The described procedure for efficient genome editing can be applied to any cell type to study physiological and pathophysiological functions in the context of precisely engineered genotypes.
27987038	10	24	genome editing	T062	UMLS:C4279981
27987038	43	48	renal	T017	UMLS:C0022646
27987038	49	65	epithelial cells	T017	UMLS:C0014597
27987038	85	112	genome editing technologies	T062	UMLS:C4279981
27987038	187	208	targeted introduction	T062	UMLS:C4279981
27987038	210	220	alteration	T062	UMLS:C4279981
27987038	226	254	removal of genomic sequences	T062	UMLS:C4279981
27987038	276	283	methods	T170	UMLS:C0025663
27987038	314	332	non-differentiated	T170	UMLS:C0449475
27987038	336	343	haploid	T017	UMLS:C1257912
27987038	344	354	cell types	T170	UMLS:C0449475
27987038	356	370	Genome editing	T062	UMLS:C4279981
27987038	394	399	renal	T017	UMLS:C0022646
27987038	400	416	epithelial cells	T017	UMLS:C0014597
27987038	449	469	technological issues	T033	UMLS:C0033213
27987038	507	555	expression of multiple genome editing constructs	T062	UMLS:C4279981
27987038	593	613	screening strategies	T170	UMLS:C0282574
27987038	679	758	generation of targeted heterozygous and homozygous genomic sequence alterations	T062	UMLS:C4279981
27987038	762	767	renal	T017	UMLS:C0022646
27987038	768	773	cells	T017	UMLS:C0007634
27987038	780	827	transcription activator-like effector nucleases	T103	UMLS:C4277678
27987038	829	835	TALENs	T103	UMLS:C4277678
27987038	845	917	clustered regularly interspaced short palindromic repeat (CRISPR) system	T103	UMLS:C3658200
27987038	965	974	protocols	T170	UMLS:C0442711
27987038	1015	1023	studying	T062	UMLS:C2603343
27987038	1024	1068	autosomal dominant polycystic kidney disease	T017	UMLS:C0085413
27987038	1070	1075	ADPKD	T017	UMLS:C0085413
27987038	1104	1148	cell culture-validated genetic modifications	T062	UMLS:C4277689
27987038	1175	1201	mouse embryonic stem cells	T017	UMLS:C4042879
27987038	1203	1208	mESCs	T017	UMLS:C4042879
27987038	1246	1251	mouse	T204	UMLS:C0025929
27987038	1252	1258	models	T204	UMLS:C0599779
27987038	1298	1312	genome editing	T062	UMLS:C4279981
27987038	1335	1344	cell type	T170	UMLS:C0449475
27987038	1348	1353	study	T062	UMLS:C2603343
27987038	1354	1367	physiological	T038	UMLS:C0031845
27987038	1372	1400	pathophysiological functions	T038	UMLS:C0030660
27987038	1429	1449	engineered genotypes	T017	UMLS:C1516876